Product Activities

Research &
Development
R&D capabilities rooted
in unique know-how centered on topical drugs in dermatology
Maruho is focusing on research and development of medical drugs focusing on topical treatments in dermatology. Maruho’s strength is its high level of late-stage development capabilities, so-called “nurturing capabilities,” including the addition of various dosage forms and indications rooted in its unique external preparation technology. In addition, we have built a system to evaluate and verify information collected from networks with researchers and medical sites in Japan and overseas. This has led to the introduction of new products and the creation of unique themes.
In order to focus on strengthening the early stage of the R&D process, we regard the results and needs obtained from basic research and clinical practice as “new concepts” that will bring about innovative changes in medical care, not only internally, but also in Japan and overseas. We are advancing R&D in collaboration with companies, academia, research institutes, and venture companies.
ManufacturingProduction systems, leading Japan
in prescription topical drug production.
Since the completion of the Hikone Plant in 1972, our mission has been to provide a stable supply of high-quality topical drugs in order to meet our mission of “ensuring the quality of pharmaceutical products and establishing a stable supply system.”
We have been actively investing management resources to strengthen our production bases and production systems, aiming to ensure safety and security in our product supply and improve the Quality of Life (QOL) of patients.
In the pharmaceutical industry, outsourcing of manufacturing is increasing. However, Maruho continues to maintain an integrated production system from the Active Pharmaceutical Ingredients (APIs) of main products to the final product.
In the future, even if some production processes are outsourced to partner companies in Japan or overseas, we will continue production activities to make topical drugs we are proud of. By strengthening our involvement in the transfer of technology and the manufacturing process according to the characteristics of each product, we will ensure high product quality and top-class volume in Japan will be maintained.
Providing InformationHigh-quality information provision
activities that reflect the voices of patients
In order to contribute widely to society through the pharmaceutical business, we are contributing to dermatology by promoting the dissemination of correct knowledge about various diseases and providing appropriate medical information.
In addition, medical representatives (MRs) provide not only Maruho product information, but medical and disease information that contributes to improving QOL responding to the diversifying needs of patients.
Global Business DevelopmentMaking high-quality contributions
to patients around the world
in collaboration with global partners
As the environment surrounding medical drugs in Japan changes drastically, the demand for drugs that meet the “unmet needs” of patients is increasing in Japan and all over the world.
Maruho aims to maximize product value by collaborating with global partners and realize contributions to health-focused consumers around the world by leveraging the high-quality information provision capabilities it has cultivated in its Japan business.
Activities other than
medical drugs for skin diseases
Developing new businesses through
collaborations with group and partner companies
Maruho will develop new businesses in order to respond to people’s desire to live better, beyond treating illnesses and prolonging lives.
In addition to the knowledge, we have cultivated through our specialization in dermatology, we will link the strengths of our group companies and promote collaboration with partner companies utilizing their strengths to complement our own. We will contribute to diversifying needs beyond the boundaries of current business regions and areas.